반응식
[N:1]1([N:7]2[NH:11][CH:10]=[C:9]([C:12]3[N:13]([CH3:20])[C:14]([N+:17]([O-:19])=[O:18])=[CH:15][N:16]=3)[S:8]2)[CH2:6][CH2:5]C[CH2:3][CH2:2]1.[CH3:21][N:22]1CCNCC1.N1CCCCC1>>[CH3:21][N:22]1[CH2:5][CH2:6][N:1]([N:7]2[NH:11][CH:10]=[C:9]([C:12]3[N:13]([CH3:20])[C:14]([N+:17]([O-:19])=[O:18])=[CH:15][N:16]=3)[S:8]2)[CH2:2][CH2:3]1참가 물질
4
실험 절차
The preparation of the above compound is carried out in the manner described for the 2-piperidino derivative (Example 28), an equivalent of 1-methylpiperazine replacing the piperidine. The crude product is purified by recrystallization from 2-methoxyethanol and melts at 242°-244° C.
후처리
- customThe preparation of the above compound
- customThe crude product is purified by recrystallization from 2-methoxyethanol and melts at 242°-244° C.
출처 및 근거
- ORD 기록
- ord-ddc0afdf3c1241b3bf665258ac784fa3
- 출처 데이터셋
- uspto-grants-1976_11
- 특허 번호
- US03991200
연결된 노트
불러오는 중…